![Ashland facility](https://www.grpva.com/wp-content/uploads/2024/11/Website-headers-44.jpg)
News | 1 min read
September 25, 2018
Kaleo, the Richmond-based pharmaceutical company that produces an epinephrine auto-injector to treat severe allergic reactions, is expanding its reach to Canada and one of the largest pharmacy outlets in the U.S. to help deal with a drug shortage.
Kaleo’s Auvi-Q injector, a direct competitor with the EpiPen, will be stocked in Walgreens, the first time a retail pharmacy in the U.S. has agreed to carry the drug.
Read the full story here.